Last updated on June 2018

A Phase 1/2 Study to Assess MultiStem Therapy in Acute Respiratory Distress Syndrome


Brief description of study

A study to examine the safety (and potential efficacy) of the adult stem cell investigational product, MultiStem, in adults who have Acute Respiratory Distress Syndrome (ARDS). The primary hypothesis is that MultiStem will be safe in ARDS patients.

Clinical Study Identifier: NCT02611609

Contact Investigators or Research Sites near you

Start Over

Anthony Ting, PhD

University Hospitals - Cleveland Medical Center
Cleveland, OH United States
  Connect »

Anthony Ting, PhD

Hospital of the University of Pennsylvania
Philadelphia, PA United States
  Connect »

Anthony Ting, PhD

University of Pittsburgh Medical Center
Pittsburgh, PA United States
  Connect »

Anthony Ting, PhD

Queen Elizabeth Hospital
Birmingham, United Kingdom
  Connect »

Anthony Ting, PhD

Addenbrooke's Hospital
Cambridge, United Kingdom
  Connect »

Anthony Ting, PhD

University College London Hospital
London, United Kingdom
  Connect »

Anthony Ting, PhD

St. Georges Hospital
London, United Kingdom
  Connect »

Anthony Ting, PhD

Manchester Royal Infirmary
Manchester, United Kingdom
  Connect »

Anthony Ting, PhD

Wythenshawe Hospital
Manchester, United Kingdom
  Connect »

Anthony Ting, PhD

John Radcliffe Hospital
Oxford, United Kingdom
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.